129118-11-2

Basic information

• Product Name: N-Methoxy-N-methylpentanamide
• Synonyms: N-Methoxy-N-methylpentanamide;N-Methylvalerohydroxamic acid methyl ester
• CAS NO: 129118-11-2
• Molecular Formula: C₇H₁₅NO₂
• Molecular Weight: 145.1995
• Mol File: 129118-11-2.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• CAS DataBase Reference: N-Methoxy-N-methylpentanamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-Methoxy-N-methylpentanamide(129118-11-2)
• EPA Substance Registry System: N-Methoxy-N-methylpentanamide(129118-11-2)

Safety Data

• Hazardous Substances Data: 129118-11-2(Hazardous Substances Data)

Usage

General Description

N-Methoxy-N-methylpentanamide, also known as N-Methyl-N-methoxypentylamine, is a chemical compound with the molecular formula C7H15NO2. It is a clear, colorless liquid with a faint amine odor. N-Methoxy-N-methylpentanamide is commonly used as a solvent or as a precursor in the synthesis of pharmaceuticals and other organic compounds. N-Methoxy-N-methylpentanamide is also known to have some potential application in the field of coatings, adhesives, sealants, and elastomers. It is important to handle this chemical with caution as it can cause irritation to the skin, eyes, and respiratory system.

Upstream product

• 693-04-9 butyl magnesium bromide 
• 6638-79-5 N,O-dimethylhydroxylamine*hydrochloride 
• 109-52-4 valeric acid 
• 84298-28-2 1H-1,2,3-benzotriazol-1-yl(n-butyl)methanone 
• 638-29-9 n-valeryl chloride 
• 109-72-8 n-butyllithium 
• 123707-26-6 N,N'-dimethoxy-N,N'-dimethyl urea 

Downstream Products

• 155955-79-6 1-<2-((tert-butoxycarbonyl)aminomethyl)phenyl>-2-hexanone 
• 138344-01-1 [4-Methoxy-2-(2-oxo-hexyl)-phenyl]-carbamic acid tert-butyl ester 
• 138344-08-8 [2-Methoxy-6-(2-oxo-hexyl)-phenyl]-carbamic acid tert-butyl ester 
• 83666-06-2 5-Butyl-3-methyl-4-(phenylmethyl)isoxazole 
• 371151-24-5 3-butyl-2,5,6,7-tetrahydro-[2]pyrindin-1-one 
• 7661-42-9 3-n-butylisoquinoline 
• 132-90-1 3-n-butyl-1(2H)-isoquinolinone 
• 25870-62-6 1-phenyl-2-hexanone 

Relevant articles and documents

CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.

Highly efficient and environmentally benign preparation of Weinreb amides in the biphasic system 2-MeTHF/water

A straightforward chromatography-free preparation of Weinreb amides starting from acid halides has been achieved in the biphasic medium 2-MeTHF/water. Analytically pure compounds were isolated in excellent yields simply after removal of 2-MeTHF, which abs

Efficient Conversions of Carboxylic Acids into O-Alkyl, N-Alkyl and O,N-Dialkylhydroxamic Acids

Carboxylic acids were conveniently converted into unsubstituted, N-alkyl-, O-alkyl-, and O,N-dialkylhydroxamic acids via acylbenzotriazole intermediates. The ready availability of the reagents, mild conditions, and easy handling of the intermediates are advantageous.